Navigation Links
Eisai To Sponsor 7th Annual National Walk For Epilepsy To Help Raise Epilepsy Awareness
Date:4/18/2013

WOODCLIFF LAKE, N.J., April 18, 2013 /PRNewswire/ -- Eisai Inc. announced today that it is a silver level sponsor of the Epilepsy Foundation's 7th Annual National Walk for Epilepsy, a family-oriented, non-competitive event to raise awareness and funds to continue fighting to stop seizures, find a cure and overcome the challenges created by epilepsy. The Walk, which unites thousands of families living with epilepsy each year, will feature activities beginning at 8 a.m. on Saturday, April 20, 2013, on the Washington Monument grounds in Washington, D.C.

(Photo: http://photos.prnewswire.com/prnh/20130418/NY95031 )

In addition to the Walk, Eisai is working with 4 Paws for Ability, an organization that trains and places service dogs with children with a variety of needs, including those with epilepsy. Seizure assistance dogs, in particular, are taught to alert children and families when the child is about to have a seizure, and get help in the event of a seizure. The dogs also provide valuable emotional support during medical procedures as well as in daily life.

At Eisai's event booth during the Walk, families will have the opportunity to meet and greet Jeremy Dulebohn , training director at 4 Paws for Ability, and his demo dog Brody. A 14-year-old who has epilepsy and her dog will also greet visitors at the booth.

"Having a service dog can give children and their families confidence and independence that will enrich their lives," said Dulebohn. "We hear countless stories about parents who worry that they may miss their child having a seizure. When we place the service dogs, we often hear that the dog has given these families their lives back. We at 4 Paws for Ability would like to thank Eisai for their partnership and help raising awareness of this life-changing resource for the epilepsy community."

Epilepsy is a medical condition that produces seizures affecting a variety of mental and physical functions. According to the Institute of Medicine, epilepsy is one of the most common neurological disorders affecting 2.2 million people in the United States. Beyond providing a place of support for the community, the National Walk for Epilepsy has raised more than $5 million in the past five years for epilepsy research as well as programs and services for people with epilepsy.

"Epilepsy is a therapeutic area of focus for Eisai and we are proud to support the Epilepsy Foundation and 4 Paws for Ability at the National Walk for Epilepsy," said Christine Verini , Vice President, Corporate Communications & Advocacy, Eisai Inc. "These partnerships support our human health care (hhc) mission of keeping the unmet medical needs of patients and their families at the forefront of all that we do."

For more information on 4 Paws for Ability, please visit www.4PawsForAbility.org. For more information on the Epilepsy Foundation's National Walk for Epilepsy, please visit www.WalkForEpilepsy.org.

About Eisai Inc.
Eisai Inc. was established in 1995 and began marketing its first product in the United States in 1997. Since that time, Eisai Inc. has rapidly grown to become a fully integrated pharmaceutical business. Eisai's key areas of commercial focus are neurology and oncology. The company serves as the U.S. pharmaceutical operation of Eisai Co., Ltd., a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. 

Eisai has a global product creation organization that includes U.S.-based R&D facilities in Massachusetts, New Jersey, North Carolina and Pennsylvania, as well as manufacturing facilities in Maryland and North Carolina. The company's areas of R&D focus include neuroscience; oncology; vascular, inflammatory and immunological reaction; and antibody-based programs. For more information about Eisai, please visit www.eisai.com/US.


'/>"/>
SOURCE Eisai Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Lynn Kramer, MD, Appointed Chief Clinical Officer of Eisai Product Creation Systems
2. FDA Grants Orphan Drug Status To Eisais Lenvatinib
3. Eisai Oncology to Present New Research on Eribulin at 35th Annual San Antonio Breast Cancer Symposium
4. Eisai USA Foundation to Donate $100,000 to the Hurricane Sandy New Jersey Relief Fund, $50,000 to the American Red Cross
5. Epilepsia Publishes Results From Two Studies Of Eisais Perampanel
6. Shaji Procida Appointed Vice President and Chief Financial Officer of Eisai Inc.
7. Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting
8. Millennium Research Group Sponsors Case Competition at Western University for Second Year
9. Abattis Provides $10,000 Sponsorship to the American Herbal Pharmacopoeia for Cannabis Monograph Project
10. Mesothelioma Symposium Gains Dedicated, Passionate Sponsor in the Nemeroff Law Firm
11. ERISA Creates Benchmarking Challenges for Plan Sponsors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... 2017  Mirabilis Medical, a Seattle ... non-invasive surgery, announced today CE Mark authorization for ... uterine fibroids throughout the European Union.  The company ... the US Food and Drug Administration to begin ... the United States.  The Mirabilis System combines high-speed ...
(Date:3/24/2017)... and GENEVA , March 24, 2017 ... Tuberculosis Day revitalizes efforts to develop sutezolid as effective ... World Tuberculosis Day, TB Alliance and the Medicines Patent ... development of sutezolid, an antibiotic drug candidate which demonstrated ... the development of sutezolid in combination with other TB ...
(Date:3/23/2017)... , Mar 23, 2017 Research and Markets ... & Trends - Industry Forecast to 2025" report to their ... The ... around 6.9% over the next decade to reach approximately $3.5 billion ... and forecasts for all the given segments on global as well ...
Breaking Medicine Technology:
(Date:3/24/2017)... , ... March 24, 2017 , ... ... first Certified Medical Reiki™ Master in Frederick, MD. Judy says, “I am passionate ... during what is often a very difficult and challenging time.” , A Certified ...
(Date:3/24/2017)... ... ... “Vintage and Harvest A Cultivation of Christian Love” is the creation of published author, ... his wife, Anna Marie. He and his wife are the proud parents of four ... of “Shadow and Substance.” , “Love, the agape kind, is seen as more than ...
(Date:3/23/2017)... NC & Seattle, WA (PRWEB) , ... March 23, 2017 , ... ... public health emergency and now estimates that there could be four million Zika-related cases ... growing epidemics to date with numbers of US cases reported per year skyrocketing to ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... services to their communities, 16 more public health departments have been awarded national ... bring another 4.5 million people into the expanding network of communities across the ...
(Date:3/23/2017)... ... March 23, 2017 , ... The IoT (Internet of Things) is revolutionizing the ... huge impact on businesses and individual consumers alike. Laboratories can maximize their profit ... value anywhere from $4 trillion to $11 trillion dollars by the year 2025. McKinsey ...
Breaking Medicine News(10 mins):